Cadila up 2% as Gujarat plant gets no USFDA observation

INSUBCONTINENT EXCLUSIVE:
observations
The scrip was up 2.14 per cent at Rs 356.10 at around 9.45 am whereas BSE Sensex rose 64 points, or 0.18 per cent, to 34,967. In a BSE
located at Ahmedabad SEZ from May 28 to June 5, 2018
At the end of the inspection, no observation (483) is issued
low of Rs 341.65 on May 22, 2018. The company had recently reported 53.26 per cent jump in consolidated net profit at Rs 590.8 crore for the
fourth quarter ended March 2018
The figure was Rs 385.5 crore in the same quarter a year ago. Consolidated sales for the period under review stood at Rs 3,152.7 crore
compared with Rs 2,452.7 crore in the previous fiscal.